1. Home
  2. Live Updates
  3. University of houston college pharmacy

Live Breaking News & Updates on University Of Houston College Pharmacy

Stay updated with breaking news from University of houston college pharmacy. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Acurx Pharmaceuticals Announces Presentation of Ibezapolstat Phase 2 Clinical Trial Results at ESCMID Global 2024 Scientific Conference

/PRNewswire/ Acurx Pharmaceuticals, Inc. (NASDAQ: ACXP) ("Acurx" or the "Company"), a clinical stage biopharmaceutical company developing a new class of. ....

United-states , Spain , Barcelona , Comunidad-autonoma-de-cataluna , Switzerland , America , Kevin-garey , Eugenie-basseres , Davidp-luci , Company-ph , Society-or-healthcare-epidemiology-of-america , Global-european-society-of-clinical-microbiology

Reduced Vancomycin Susceptibility Tied to Poorer C difficile Outcomes

Poorer outcomes seen for 30-day sustained clinical response and 14-day initial cure rates. ....

Kevin-garey , Taryna-eubank , University-of-houston , University-of-houston-college-pharmacy , Healthday-news , Clinical-infectious , Houston-college ,

Vancomycin May Be Losing Strength Against Common Deadly Infection

Key Takeaways ....

University-of-houston , Texas , United-states , Houston , Americans , Kevin-garey , Anne-gonzales-luna , Us-centers-for-disease , University-of-houston-college-pharmacy , Healthday-news , Houston-college

Vancomycin may be losing effectiveness against C. diff

A new study suggests that the leading antibiotic used to fight Clostridioides difficile, vancomycin, may be losing potency against this killer. ....

University-of-houston , Texas , United-states , Houston , Americans , Kevin-garey , Anne-gonzales-luna , Us-centers-for-disease , University-of-houston-college-pharmacy , Houston-college , Disease-control

Acurx Pharmaceuticals Announces Presentation of Ibezapolostat Phase 2 Clinical Trial Results at upcoming ESCMID 2024 Scientific Conference

/PRNewswire/ Acurx Pharmaceuticals, Inc. (NASDAQ: ACXP) ("Acurx" or the "Company"), a clinical stage biopharmaceutical company developing a new class of. ....

United-states , Spain , Switzerland , Barcelona , Comunidad-autonoma-de-cataluna , America , Kevin-garey , Eugenie-basseres , Davidp-luci , Society-or-healthcare-epidemiology-of-america , Exchange-commission , Research-scientist